Both TREK-1 and TREK-2 are widely expressed inthe mammalian CNS, as well as the periphery, and activation of eitherTREK-1, TREK-2 or both channels have potential therapeutic utilityin pain, migraine, ischemia, and arrhythmia among others. The gene discussed is KCNK10; the disease is cardiac arrhythmia.